Literature DB >> 9211196

Hepatic porphyrias in children.

G H Elder1.   

Abstract

Clinically overt hepatic porphyria is uncommon in children. The autosomal dominant acute hepatic porphyrias, acute intermittent porphyria (AIP), variegate porphyria (VP) and hereditary coproporphyria (HCP), are rarely present before puberty. Identification of asymptomatic children who have inherited these disorders is an important aspect of the management of the disease in their families and requires either enzymatic or DNA methods. Homozygous variants of AIP, VP and HCP usually present in early childhood and have phenotypes of variable severity. Mutational analysis is currently elucidating the relationship between these disorders and their autosomal dominant counterparts. 5-Aminolaevulinate dehydratase deficiency porphyria is a rare, autosomal recessive acute porphyria that may present at any age. Two cutaneous hepatic porphyrias are seen in children. Porphyria cutanea tarda (PCT), although mainly an adult disease, has been reported in young children with the autosomal dominant (type II) form of the disorder. Hepatoerythropoietic porphyria usually develops before the age of 2 years; patients are homo- or heteroallelic for uroporphyrinogen decarboxylase mutations, at least one of which is known to cause type II PCT.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9211196     DOI: 10.1023/a:1005313024076

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  33 in total

1.  [Acute intermittent porphyria at 4 months of age].

Authors:  P Beauvais; M L Klein; L Denave; C Martel
Journal:  Arch Fr Pediatr       Date:  1976-12

2.  Homozygous variegate porphyria: a case report.

Authors:  P G Norris; G H Elder; J L Hawk
Journal:  Br J Dermatol       Date:  1990-02       Impact factor: 9.302

3.  A molecular defect in coproporphyrinogen oxidase gene causing harderoporphyria, a variant form of hereditary coproporphyria.

Authors:  J Lamoril; P Martasek; J C Deybach; V Da Silva; B Grandchamp; Y Nordmann
Journal:  Hum Mol Genet       Date:  1995-02       Impact factor: 6.150

4.  Harderoporphyria: a variant hereditary coproporphyria.

Authors:  Y Nordmann; B Grandchamp; H de Verneuil; L Phung; B Cartigny; G Fontaine
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

5.  Homozygous case of hereditary coproporphyria.

Authors:  B Grandchamp; N Phung; Y Nordmann
Journal:  Lancet       Date:  1977 Dec 24-31       Impact factor: 79.321

6.  Neurologic crises in hereditary tyrosinemia.

Authors:  G Mitchell; J Larochelle; M Lambert; J Michaud; A Grenier; H Ogier; M Gauthier; J Lacroix; M Vanasse; A Larbrisseau
Journal:  N Engl J Med       Date:  1990-02-15       Impact factor: 91.245

Review 7.  Porphobilinogen deaminase gene structure and molecular defects.

Authors:  J C Deybach; H Puy
Journal:  J Bioenerg Biomembr       Date:  1995-04       Impact factor: 2.945

Review 8.  Molecular abnormalities of coproporphyrinogen oxidase in patients with hereditary coproporphyria.

Authors:  B Grandchamp; J Lamoril; H Puy
Journal:  J Bioenerg Biomembr       Date:  1995-04       Impact factor: 2.945

9.  Porphyria turcica due to hexachlorobenzene: a 20 to 30 year follow-up study on 204 patients.

Authors:  D J Cripps; H A Peters; A Gocmen; I Dogramici
Journal:  Br J Dermatol       Date:  1984-10       Impact factor: 9.302

10.  Hereditary hepatic porphyria due to homozygous delta-aminolevulinic acid dehydratase deficiency: studies in lymphocytes and erythrocytes.

Authors:  S Sassa; H Fujita; M Doss; A Hassoun; L Verstraeten; R Mercelis; A Kappas
Journal:  Eur J Clin Invest       Date:  1991-04       Impact factor: 4.686

View more
  10 in total

1.  Characterization of mutations in the CPO gene in British patients demonstrates absence of genotype-phenotype correlation and identifies relationship between hereditary coproporphyria and harderoporphyria.

Authors:  J Lamoril; H Puy; S D Whatley; C Martin; J R Woolf; V Da Silva; J C Deybach; G H Elder
Journal:  Am J Hum Genet       Date:  2001-04-16       Impact factor: 11.025

2.  Hepatoerythropoietic porphyria misdiagnosed as child abuse: cutaneous, arthritic, and hematologic manifestations in siblings with a novel UROD mutation.

Authors:  Julie L Cantatore-Francis; Jessica Cohen-Pfeffer; Manisha Balwani; Philip Kahn; Herbert M Lazarus; Robert J Desnick; Julie V Schaffer
Journal:  Arch Dermatol       Date:  2010-05

3.  Psychosocial aspects of predictive genetic testing for acute intermittent porphyria in norwegian minors.

Authors:  Janice Andersen; Sverre Sandberg; Maalfrid Raaheim; Eva Gjengedal
Journal:  JIMD Rep       Date:  2011-06-22

Review 4.  Porphyria Diagnostics-Part 1: A Brief Overview of the Porphyrias.

Authors:  Vaithamanithi-Mudumbai Sadagopa Ramanujam; Karl Elmo Anderson
Journal:  Curr Protoc Hum Genet       Date:  2015-07-01

Review 5.  Erythropoietic and hepatic porphyrias.

Authors:  U Gross; G F Hoffmann; M O Doss
Journal:  J Inherit Metab Dis       Date:  2000-11       Impact factor: 4.982

Review 6.  The porphyrias: advances in diagnosis and treatment.

Authors:  Manisha Balwani; Robert J Desnick
Journal:  Blood       Date:  2012-07-12       Impact factor: 22.113

7.  Evaluation of urinary porphyrin excretion in neonates born to mothers exposed to airborne hexachlorobenzene.

Authors:  Dolores Ozalla; Carmen Herrero; Núria Ribas-Fitó; Jordi To-Figueras; Agustí Toll; Maria Sala; Joan Grimalt; Xavier Basagaña; Màrius Lecha; Jordi Sunyer
Journal:  Environ Health Perspect       Date:  2002-02       Impact factor: 9.031

8.  Neuropathic pain in hereditary coproporphyria.

Authors:  Guan-Liang Chen; Deng-Ho Yang; Jeng-Yuau Wu; Chia-Wen Kuo; Wen-Hsiu Hsu
Journal:  Pak J Med Sci       Date:  2013-04       Impact factor: 1.088

Review 9.  Acute Intermittent Porphyria: An Overview of Therapy Developments and Future Perspectives Focusing on Stabilisation of HMBS and Proteostasis Regulators.

Authors:  Helene J Bustad; Juha P Kallio; Marta Vorland; Valeria Fiorentino; Sverre Sandberg; Caroline Schmitt; Aasne K Aarsand; Aurora Martinez
Journal:  Int J Mol Sci       Date:  2021-01-12       Impact factor: 5.923

Review 10.  Challenges in diagnosis and management of acute hepatic porphyrias: from an uncommon pediatric onset to innovative treatments and perspectives.

Authors:  Matteo Marcacci; Andrea Ricci; Chiara Cuoghi; Stefano Marchini; Antonello Pietrangelo; Paolo Ventura
Journal:  Orphanet J Rare Dis       Date:  2022-04-07       Impact factor: 4.123

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.